Watchlist Price Alert

Acurx Pharmaceuticals Inc... (ACXP)

NASDAQ: ACXP · Real-Time Price · USD

0.35

0.00 (0.73%)

At close: Jun 06, 2025, 3:59 PM

0.34

-3.38%

After-hours: Jun 06, 2025, 05:57 PM EDT

Acurx Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Net Income	-11.88M	-14.1M	-16.44M	-16.73M	-16.05M	-14.58M	-12.72M	-13.15M	-12.33M	-12.09M	-11.46M	-12.56M	-13.94M	-12.75M	-11.21M	-7.89M	-4.79M	-4.6M	-3.51M	-2.19M	-1.28M
Depreciation & Amortization	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Stock-Based Compensation	2.32M	3.07M	3.76M	4.28M	4.07M	3.77M	3.24M	3.23M	3.14M	3.19M	3.07M	5.65M	7.19M	6.56M	6.27M	3.18M	1.09M	1.11M	821.08K	514.43K	347.77K
Other Working Capital	-607.84K	-225.06K	-481.99K	-167.92K	925.79K	-11.36M	-11.31M	-10.96M	-11.74M	211.28M	211.53M	209.6M	210.8M	-246.69K	-377.96K	1.26M	-368.22K	-801.17K	-648.67K	-897.81K	-749.66K
Other Non-Cash Items	1.12B	1.12B	1.03M	1.55M	2.24M	3.07M	3.49M	3.37M	2.26M	1.15M	648.38K	-13.76K	78.89K	1.21M	784.35K	1.11M	1.18M	1.05M	1.16M	781.7K	781.7K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-510.6K	-49.77K	-1.36M	-1.05M	-901.32K	-945.5K	1.33M	968.77K	924.46K	698.81K	113.1K	-1.11M	302.75K	140.75K	-266.52K	1.13M	-500.24K	-933.24K	-892.72K	-898K	-750K
Operating Cash Flow	-9.37M	-10.38M	-12.33M	-12.23M	-10.93M	-9.8M	-7.1M	-7.19M	-7.6M	-7.54M	-7.55M	-8M	-6.34M	-5.01M	-4.47M	-2.6M	-3M	-3.35M	-2.39M	-1.63M	-899K
Capital Expenditures	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	66.5K	66.5K	66.5K	66.5K	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	9.6B	6.62B	6.42B	8.69M	8.37M	8.16M	-151.5K	86.00	13.00	13.00	14.79B	14.78B	14.78B	14.78B	n/a	n/a	1.12M	1.12M	1.12M	1.12M	n/a
Financial Cash Flow	9.41B	6.42B	6.43B	9.45M	12.67M	8.16M	3.54M	7.24M	3.69M	3.69M	14.79B	14.78B	14.8B	14.8B	15.53M	17.72M	4.04M	4.04M	3.31M	1.12M	n/a
Net Cash Flow	931.96M	-3.77M	-1.29M	-2.79M	1.74M	-1.64M	-3.56M	53K	-3.9M	-3.85M	-3.85M	-8M	8.45M	9.78M	11.05M	15.12M	1.04M	692.41K	923.41K	-508.59K	-899K
Free Cash Flow	-9.37M	-10.38M	-12.33M	-12.23M	-10.93M	-9.8M	-7.1M	-7.19M	-7.6M	-7.54M	-7.55M	-8M	-6.34M	-5.01M	-4.47M	-2.6M	-3M	-3.35M	-2.39M	-1.63M	-899K